Lung cancer breakthrough: chemo spares Low-Risk patients
NCT ID NCT07250360
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study involved over 2,000 people with early-stage non-squamous lung cancer who had surgery. Researchers wanted to see if adding chemotherapy after surgery helped prevent the cancer from coming back. They found that chemotherapy only improved survival for patients with high-risk features, not for everyone. The team also created a computer tool to help doctors decide who should get chemo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER STAGE I are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Radiation and immunotherapy join forces against early lung cancer
- Inhaled therapy aims to cut lung Tumors' sugar supply
- Dye vs. air: which better guides lung cancer surgery?
- New combo therapy aims to stop lung cancer from returning
- Blood test guides new attack on lung cancer return
- No-Marker tumor tracking could make lung cancer radiation safer